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The prechylomicron transport vesicle (PCTV) is an enlarged, COPII-containing vesicle that transports the developing chylomicron from the ER (endoplasmic reticulum)
to the Golgi (1, 2). This largest of the lipoproteins is
uniquely formed in the intestine and is the primary mech-
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anism by which dietary fat is delivered to peripheral targeted tissues, muscle, heart, and adipose tissue. The
majority of the triacylglycerol (TAG) in the chylomicron is
derived from hydrolytic products of dietary lipids that are
resynthesized to TAG by the intestinal ER. The newly synthesized TAG crosses the ER membrane and forms the
prechylomicron in the ER lumen in a two-step process (3).
The exit step of the prechylomicron from the ER is the
rate-limiting step by which dietary TAG traverses the intestinal absorptive cell (4) (5). Once detached from the ER
membrane, the PCTV dock and then fuse with the Golgi
using the N-ethylmaleimide sensitive factor attachment
protein receptor (SNARE) complex composed of VAMP7
(the R-SNARE), syntaxin5 (the Qa-SNARE), vti1A (the
Qb-SNARE), and Bet1 (the Qc-SNARE) (2).
Our interest in the molecular mechanism of the docking of PCTV with the Golgi in relation to the COPII proteins was raised by these findings: (a) Although PCTV
could be generated from ER membranes in the absence of
Sar1, the initiator of the COPII complex, the vesicles
formed could not fuse with the Golgi (1). The vesicles
were of the same size as PCTV generated using native cytosol, contained apolipoproteinB48 (apoB48), the quintessential chylomicron apolipoprotein, and VAMP7, the
R-SNARE of the PCTV-Golgi SNARE complex; however,
neither docking nor fusion was possible using these vesicles. b) The liver-fatty acid binding protein (L-FABP) can,
in the absence of additional cytosolic components, elaborate PCTV from intestinal ER membranes (6). However, in
support of the data obtained using vesicles formed in the
absence of Sar1, these L-FABP formed vesicles do not contain COPII proteins and cannot fuse with the Golgi. In
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protein receptor; TAG, triacylglycerol; VAMP7, vesicle associated membrane protein 7.
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Abstract The rate-limiting step in the transit of dietary fat
across the intestinal absorptive cell is its exit from the endoplasmic reticulum (ER) in a specialized ER-to-Golgi transport vesicle, the prechylomicron transport vesicle (PCTV).
PCTV bud off from the ER membranes and have unique
features; they are the largest ER-derived vesicles (average
diameter 250 nm), do not require GTP and COPII proteins
for their formation, and utilize VAMP7 as a v-N-ethylmaleimide sensitive factor attachment protein receptor
(SNARE). However, PCTV require COPII proteins for their
fusion with the Golgi, suggesting a role for them in Golgi
target recognition. In support of this, PCTV contained each
of the five COPII proteins when docked with the Golgi.
When PCTV were fused with the Golgi, the COPII proteins
were present in greatly diminished amounts, indicating they
had cycled back to the cytosol. Immuno-depletion of Sec31
from the cytosol did not affect PCTV-Golgi docking, but
depletion of Sec23 resulted in a 25% decrease. Immunodepletion of Sec24C caused a nearly complete cessation of
PCTV docking activity, but on the addition of recombinant
Sec24C, docking activity was restored. We conclude that
the COPII proteins are present at docking of PCTV with the
Golgi and that Sec24C is required for this event. Sec23 plays
a less important role.—Siddiqi, S., S. A. Siddiqi, and C. M.
Mansbach II. Sec24C is required for docking the prechylomicron transport vesicle with the Golgi. J. Lipid Res. 2010.
51: 1093–1100.

MATERIALS AND METHODS
Materials
3
H-Oleic acid (9.2 Ci/mM) was procured from Perkin Elmer
Life Sciences. Immunoblot reagents were purchased from BioRad. Enhanced chemiluminescence (ECL) reagents were procured from GE Healthcare. Protease inhibitor cocktail tablets
were obtained from Roche Applied Science. Other biochemicals
used were analytical grade and purchased from Sigma (Sigma
Chemical Co., St. Louis, MO) or local companies. Male Sprague
Dawley rats, 150–200 g were purchased from Harlan (Indianapolis, IN) and fed rat chow ad lib including the night prior to sacrifice. All research was done in accordance with NIH policies and
was approved by the University of Tennessee Health Science
Center Institutional Animal Use and Care Committee.

Antibodies and protein
Rabbit anti-Sar1 antibodies were raised commercially (Protein
Tech Group, Chicago, IL) using recombinant Sar1 protein
(Siddiqi et al., 2003). Polyclonal antibodies against rat VAMP7
were raised in rabbits against amino acids 105-123 of rat VAMP7
(14). Affinity-purified rabbit polyclonal anti-Sec24C antibodies
were a gift of J.P. Paccaud (University of Geneva, Geneva, Switzerland). Rabbit polyclonal antibodies against Sec13 and Sec31 were
a generous gift of Dr. F. S. Gorelick (Yale University, New Haven,
CT). Goat anti-Sec 23 antibodies and rabbit polyclonal antibody
to syntaxin 5 were procured from Santa Cruz Biotechnology
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(Santa Cruz, CA). Mouse monoclonal antibodies to rBet1 were
procured from Stressgen (Vancouver, Canada). Mouse anti-vti1a
monoclonal antibodies were purchased from BD Biosciences.
Rabbit polyclonal anti-apolipoprotein AI (apoAI) antibodies
were a gift of Dr. Patrick Tso (University of Cincinnati, Cincinnati, OH). Sec24C recombinant protein was purchased from
Novus Biologicals, Inc. (Littleton, CO). Goat anti-rabbit IgG conjugated with agarose beads was purchased from Sigma. Goat antirabbit IgG and goat anti-mouse IgG conjugated with horseradish
peroxidase (HRP) were procured from Sigma.

Preparation of ER, Golgi, cytosol, and labeling of
enterocytes
Enterocytes from the proximal half of male Sprague Dawley
rat small intestine were isolated and radiolabeled with 3H-oleate
as described (15). In brief, enterocytes were isolated from intestinal villi, collected, incubated with albumin bound 3H-oleate for
30 min at 35°C and washed twice with PBS containing 2% BSA to
remove the excess 3H-oleate. The labeled enterocytes were homogenized using a Parr bomb and the ER was isolated using a
sucrose step gradient that was repeated to purify the ER. The
purified ER contained calnexin and calreticulin, markers proteins for ER, but neither GOS28 nor rab11, markers for Golgi
and endosomes, respectively (1, 14). The Golgi was isolated from
non-radiolabeled enterocytes as was cytosol (1, 16). Marker proteins assessed the purity of Golgi.

Depletion of specific COPII proteins from the cytosol
and ER
Depletion of specific COPII proteins from intestinal cytosol
was accomplished by incubating cytosol (1 mg protein) with 10l
of specific primary antibody at 4°C for 4 h. The antibody bound
COPII proteins and any excess antibody were removed by incubation with anti-goat IgG bound to agarose beads or with anti-rabbit
IgG bound to agarose beads at 4°C overnight and the beads removed by centrifugation. Depletion required two or three rounds
of antibody treatment. Depletion was confirmed by immunoblot
using specific antibodies. Depletion of specific ER proteins was
accomplished by washing the ER membranes with 2M urea that
was confirmed by immunoblot. In all studies using a specific
COPII protein(s)-depleted system, both cytosol and ER were
depleted.

In vitro PCTV formation
PCTV containing 3H -TAG was formed from 3H-TAG loaded
intestinal ER (1)). In brief, ER containing 3H -TAG (500 g protein) was incubated at 37°C for 30 min with cytosol (1 mg protein) and an ATP-regenerating system in the absence of Golgi
acceptor (total volume 500 µl). The incubation mixture was resolved on a continuous sucrose density gradient (0.1–1.15 M sucrose) and PCTV isolated from the light portions of the gradient.
PCTV thus formed were concentrated using a Centricon-10 filter
(Millipore Corp., Bedford, MA).
Specific COPII protein depleted PCTV were generated by using specific COPII protein depleted cytosol and ER. For example,
Sec23- or Sec24C-depleted PCTV were generated from Sec23- or
Sec24C-depleted cytosol and ER.

In vitro docking of PCTV with Golgi
PCTV (150 g protein) containing 3H-TAG were incubated
with Golgi membranes (300 g protein) and 500 g cytosolic
protein with 30 mM HEPES buffer containing 0.25M sucrose, 30
mM KCl, 5 mM CaCl2, 1 mM EDTA and 2 mM DTT for 1 h at 4°C
(total volume 500 µl). The incubation mixture was resolved on a
sucrose step gradient, and the Golgi fraction obtained by aspira-
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sum, the data strongly suggested to us that COPII proteins
played a role in the docking process with the Golgi.
Vesicles that take newly synthesized proteins from the
ER to the Golgi are well described and require COPII proteins for their generation from ER membranes. These
COPII proteins have been divided into an inner coat containing Sar1 and Sec23/24, and an outer coat containing
Sec13/31 (7). In this construct, Sar1, in its GTP bound
form, is recruited to the ER membrane and subsequently
recruits Sec23/24 and then Sec13/31. These events occur
in the presence of potential cargo for the vesicle at specific
ER exit sites (ERES) (8–10). The completed structure
then deforms the ER membrane and, in a fission step, is
detached from the membrane. Most of these vesicles are
remarkably uniform in size, ⵑ60 nm (11). Their size is
constrained by the heterodimer Sec13/31, which forms a
cage around the vesicle. However, new data from the Balch
laboratory (12) suggest that the angles of the cage components can be altered to some degree to allow for enlarging
the cage to encompass larger cargos, up to 100 nm (12).
This is still not large enough to enable a chylomicron of
250 nm to be enclosed within the cage structure. By contrast, PCTV are large enough to contain chylomicrons and
have been measured up to 350 nm (1).
The total data suggest that the COPII proteins are used
by PCTV not as a vesicle generation mechanism but rather
as a required Golgi targeting mechanism in addition to
the R-SNARE VAMP7. As part of the targeting mechanism,
the COPII proteins may not uncoat prior to the docking
event of the PCTV with the Golgi. This report tests this
hypothesis that has received support from recent data using COPII-dependent, protein vesicles (13).

tion (14). 3H-TAG was extracted (17) from the Golgi, and the
radioactivity determined in a liquid scintillation spectrometer.
To determine the effect of Sec23, Sec24C, or Sec31 depletion
on PCTV-Golgi docking, Sec23-, Sec24C-, or Sec31-depleted cytosol and Sec23-, Sec24C-, or Sec31-depleted PCTV were used in
the docking assay. These data were compared with PCTV docking activity after immuno-depletion with IgG. When recombinant
Sec24C (rSec24C) was added back to Sec24C immuno-depleted
cytosol for purposes of restoring docking activity, the rSec24C
(7.25, 14.5, or 29 µg protein as indicated) was incubated with
Sec24C immuno-depleted cytosol and Sec24C-depleted PCTV
for 30 min at 4°C prior to starting the docking assay. The repleted cytosol and PCTV were used in the docking assay with
Golgi membranes as described above.
When anti-Sec24C antibodies were used in PCTV-Golgi docking experiments, native cytosol was used to generate PCTV. The
native PCTV were incubated with anti-Sec24C antibodies (20 µl)
for 40 min at 4°C prior to docking. The antibody-treated PCTV
were then used in the docking assay with native cytosol and Golgi
membranes.

PCTV fusion with the Golgi was performed by incubating 3HTAG loaded-PCTV (150 µg protein) with Golgi membranes (300
µg protein) and native cytosol (500 µg protein) for 30 min at
35°C with an ATP regenerating system, 5 mM MgCl2, 0.25M sucrose, 30 mM HEPES, pH 7.2, 30 mM KCl, 5 mM CaCl2, and 2
mM DTT; total volume, 500l (2). Postincubation, the Golgi
membranes were separated from un-reacted PCTV by a sucrose
step gradient, and the Golgi-associated TAG radioactivity was determined (2).

Isolation of PCTV-Golgi SNARE complex
Isolation of the SNARE complex was accomplished by solubilizing PCTV docked with Golgi (200 g) using 2% Triton X-100
in PBS as described (2). In brief, the solubilized proteins were
incubated overnight at 4°C with anti-rabbit VAMP7 antibody
bound to anti-rabbit IgG conjugated with agarose beads. The
beads were collected by centrifugation, washed eight times with
PBS to remove unbound proteins/antibodies, and resuspended
in Laemmle’s buffer for immunoblot analysis. The beads were
either boiled or not boiled in Laemmle’s buffer as indicated. The
immuno-precipitated proteins were separated by SDS-PAGE,
then transblotted onto nitrocellulose membranes (Bio-Rad). The
same membrane was probed with antibodies to VAMP7, syntaxin
5, vti1a, and rBet1.
In experiments where the ability of rSec24C to reestablish
Sec24C depleted PCTV-Golgi docking was tested, 29 µg rSec24C
were incubated with Sec24C depleted-PCTV (150 µg prot) and
Sec24C depleted-cytosol (500 µg prot) for 60 min at 4°C. The
Sec24C repleted PCTV were then incubated with Golgi membranes (300 µg prot) as for docking and the SNARE complex
isolated as described (2).

SDS-PAGE and immunoblots
Proteins were separated by SDS-PAGE, then transblotted onto
nitrocellulose membranes (Bio-Rad) (1). After incubation with
specific primary antibodies and peroxidase-conjugated secondary antibodies, proteins were detected by ECL (Amersham Biosciences) and Biomax film (Eastman Kodak, Rochester, NY).

Measurement of TAG radioactivity
TAG radioactivity was determined by liquid scintillation spectroscopy (15).

COPII proteins are present at PCTV docking with the Golgi
In contrast to older information (18), more recent data
would suggest that ER-to-Golgi transport vesicles which
contain COPII proteins are attached to Golgi tethering
proteins prior to their eventual fusion with the Golgi (13).
We wished to determine if that were true for PCTV and
Golgi membranes in the intestine. To this end, we incubated PCTV, which contain all the COPII proteins (Fig.
1A, lane 1) with Golgi under conditions that favor docking
(2). Although the Golgi gave a weak signal for each of the
COPII proteins prior to incubation (Fig. 1A, lane 2), after
a 60 min incubation with PCTV, the COPII proteins in the
Golgi gave a much stronger signal (Fig. 1A, lane 3). One
interpretation of these data is that the COPII proteins on
PCTV do not un-coat prior to docking with the Golgi and
thus remain during the docking process resulting in their
increased concentration on isolation of the Golgi. Under
conditions in which fusion with the Golgi would be expected (2), the signals for all the COPII proteins were
greatly diminished (Fig. 1A, lane 4), suggesting that the
COPII proteins returned to cytosol after fusion. To establish that PCTV were fused with the Golgi, we took advantage of our prior observation that prechylomicrons in
PCTV do not contain apoAI (1). However, apoAI is present in the Golgi lumen (1, 2) and becomes associated with
the prechylomicrons when they enter the Golgi lumen after PCTV-Golgi fusion (1, 2). In the current experiments,
as before, prechylomicrons in PCTV contain no apoAI
(Fig. 1B, chylo), and the few chylomicrons isolated from

Fig. 1. The effect of docking and fusion of PCTV with Golgi
membranes on COPII proteins and chylomicron acquisition of
apoAI on fusion with the Golgi. A: Equal amounts of proteins (40
µg) were separated by 12% SDS-PAGE, transblotted to nitrocellulose membranes, and the proteins detected by ECL using specific
antibodies to the COPII proteins as indicated. The presence of the
COPII proteins was detected in PCTV (lane 1), Golgi (lane 2),
PCTV docked with the Golgi (lane 3), and PCTV fused with the
Golgi (lane 4). Methods for docking and fusion of PCTV with the
Golgi are described in “Materials and Methods.” B: Chylomicrons
isolated from PCTV (lane 1), Golgi prior to fusion with PCTV (lane
2), and Golgi after fusion with PCTV (lane 3) were obtained and
their proteins separated by SDS-PAGE. After transblotting, apoAI
was identified by ECL using specific antibodies. ECL, enhanced
chemiluminescence; PCTV, prechylomicron transport vesicle.

PCTV requires Sec24C for docking with the Golgi

1095

Downloaded from www.jlr.org at UNIV OF CENTRAL FLORIDA, on March 19, 2019

In vitro PCTV fusion with the Golgi

RESULTS

the Golgi lumen by carbonate treatment show small
amounts of apoAI (Fig. 1B, Golgi). By contrast, under
conditions where fusion of the PCTV with the Golgi is
expected, the Golgi lumen becomes enriched with chylomicrons and the amount of apoAI associated with them is
greatly (3-fold) increased (Fig. 1B, Golgi post fusion), supporting our prior data (1, 2).

Fig. 2. The effect of Sec23 depletion from the cytosol and ER on
PCTV docking with Golgi membranes. A: Sec 23 was immunodepleted from native rat cytosol using specific antibodies. 40 µg of
cytosolic protein was separated by SDS-PAGE and Sec23 or Sec24C
identified by ECL. Cytosol was immunodepleted by IgG or anti-Sec
23 antibodies as indicated. PCTV were generated using IgG depleted or Sec23 immunodepleted cytosol and its proteins separated
by SDS-PAGE. Sec23 or Sec24C was identified by immunoblot using anti-Sec23 or Sec24C antibodies as shown. B: PCTV (150 µg
protein) were generated using IgG or Sec23 immunodepleted cytosol and were docked with Golgi membranes (300 µg protein). The
3
H-TAG-dpm associated with the Golgi was determined in each
case (ordinate). The P value tests the differences between the
means ± 1 SEM, N = 4. ECL, enhanced chemiluminescence; ER,
endoplasmic reticulum; PCTV, prechylomicron transport vesicle;
TAG, triacylglycerol.
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Immunodepletion of Sec24C and its effect on
PCTV-Golgi docking
Because immuno-depletion of Sec23 seemed to have
only a modest effect on PCTV-Golgi docking, we immunodepleted Sec24C from cytosol using specific antibodies.
This resulted in the removal of Sec24C from the cytosol
(Fig. 3A, compare IgG depleted cytosol with Sec24C depleted cytosol). Densitometric analysis revealed that some
(73%) Sec23 remained (Fig. 3A, Sec24C depl), presumably because only Sec24C was removed, leaving Sec23 potentially complexed to the remaining Sec24 paralogs
(Sec24A, B, or D). When the Sec24C-depleted cytosol was
used in place of IgG-depleted cytosol in the generation of
PCTV from Sec24C-depleted ER membranes, the PCTV
produced were also devoid of Sec24C, as expected (Fig.
3A, compare PCTV formed in IgG- depleted cytosol with
PCTV formed in Sec24C-depleted cytosol). Importantly,
the modest reduction in Sec31 seen in the cytosol in the
Sec24C-depleted cytosol was not reflected in the intensity of
the Sec31 signal on Sec24C-depleted PCTV (Fig. 3, lane 4).
When 3H-TAG loaded Sec24C-depleted PCTV were
tested for their ability to fuse with the Golgi, they were unable to do so (Fig. 3B, Dep), whereas PCTV generated using IgG-depleted cytosol gave a robust 3H-TAG signal in
the Golgi (Fig. 3B, IgG). These data highlight the important role played by Sec24C in PCTV target recognition. An
alternative explanation of the data is that the anti-Sec24C
antibodies removed not only Sec24C but one or more
other unknown proteins that are important for Golgi
docking and that the effect seen on immuno-depletion is
due to the lack of this protein(s) rather than the lack of
Sec24C. To address this question, we repleted Sec24Cdepleted cytosol with increasing amounts of recombinant
Sec24C (Fig. 3B). After adding 7.25 µg Sec24C, no increase in docking was seen. However, as the amount of
Sec24C was increased, PCTV docking with the Golgi progressively increased, reaching 74% the activity of IgGdepleted cytosol when 29 µg Sec24C was added (Fig. 3B)
(29). As measured by semi-quantitative immunoblot, cytosol contains 1.2 µg Sec 24C/mg prot. The excess rSec24C
required to be added to restore nearly full docking activity
presumably relates to the GST tag on the recombinant
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Immunodepletion of Sec23 and its effect on PCTV-Golgi
docking
Our next aim was to determine which of the COPII proteins was primarily important for target recognition for
PCTV with the Golgi. We have previously shown that in the
absence of Sar1, PCTV do not fuse with the Golgi (1, 6).
We next considered Sec23. As expected, intestinal cytosol
contained significant amounts of Sec23 as shown by its
strong signal on immunoblot (Fig. 2A, lane 1). By contrast,
using bead-bound specific anti-Sec23 antibodies, Sec 23
was completely removed from the cytosol by the immunodepletion (Fig. 2A, lane 2). PCTV generated in IgG-depleted
cytosol contained Sec23 (Fig. 2A, lane 3), whereas PCTV
formed in Sec23-depleted cytosol did not (Fig. 2A, lane 4),

as expected. Sec24C was modestly reduced by the immunodepletion of Sec23 (Fig. 2A, Sec24C).
When 3H-TAG loaded PCTV generated in IgG immunodepleted cytosol were incubated with Golgi membranes
under conditions favoring docking (2), a robust 3H-TAG
signal was obtained in the Golgi fraction, indicating significant amounts of docking (Fig. 2B, IgG). However,
when PCTV generated in Sec23-depleted cytosol were incubated with Golgi under conditions favoring docking, a
25% reduction in the ability of the Sec23-depleted PCTV
to dock with the Golgi was found (Fig. 2A, Sec23 dep).
The reduced docking activity of the Sec23-depleted cytosol may be due to partial Sec24C reduction as a result of
the Sec23 depletion (Fig. 2A, Sec24C). An interpretation
of these data is that Sec23, while important as a Golgi targeting signal, is not required for docking to occur.

immuno-depleted cytosol of Sec31 (data not shown) and
used this cytosol to bud 3H-TAG loaded PCTV from ER
membranes. By contrast to the data obtained with Sec23
and Sec24C immuno-depletion, on Sec31 removal, only a
modest, nonsignificant reduction was seen (Fig. 4).

protein, potential glycosylation changes in the recombinant as compared with the native protein (19), and the
structural integrity of the rSec24C. These data show the
importance of Sec24C on PCTV as a contributory Golgitargeting mechanism with the R-SNARE VAMP7 (2).
Immunodepletion of Sec31 and its effect on PCTV-Golgi
docking
We considered the possibility that Sec31 could also have
an effect on PCTV docking. To address this possibility, we

Fig. 4. The effect of Sec31 immunodepletion on PCTV docking
with intestinal Golgi. Cytosol immunodepleted of Sec31 (data not
shown) using specific anti-Sec31 antibodies or IgG was used to generate PCTV. PCTV (150 µg protein) formed using these cytosols
were docked with intestinal Golgi (300 µg protein) as described in
3
“Materials and Methods.” After incubation, the number of H-TAGdpm associated with the Golgi was determined. IgG indicates PCTV
formed in IgG depleted cytosol and Sec31 dep indicates Sec31 depleted cytosol. The data are the means ± 1 SEM, N = 4. PCTV, prechylomicron transport vesicle; TAG, triacylglycerol.

PCTV requires Sec24C for docking with the Golgi
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Fig. 3. Depletion of Sec24C from cytosol and ER impairs PCTVGolgi docking. A: The effect of Sec24C immuno-depletion of cytosol on cytosolic COPII proteins. Cytosol: Rat intestinal cytosol was
either immunodepleted with IgG (IgG) or anti-Sec24C antibodies
(Sec24C Depl) as indicated and the cytosol probed for the COPII
proteins using specific antibodies. 40 µg cytosolic protein was separated by SDS-PAGE and the COPII proteins identified using ECL
after transblotting. The Sec23 band density of cytosol was quantitated using the Gel Doc XR Imaging System (BioRad). PCTV:
PCTV (40 µg prot) formed using either IgG (IgG) or Sec24C immunodepleted (Sec24C Depl) cytosol was immunoblotted for the
COPII proteins including Sec24C after separation by SDS-PAGE
and the proteins identified by ECL after transblotting. B: The effect of Sec24C immunodepleted cytosol on PCTV docking with the
Golgi and the effect on docking activity of adding recombinant
Sec24C to Sec24C depleted cytosol. PCTV were generated in either
IgG depleted (IgG) or Sec24C depleted rat intestinal cytosol to
which either none (Dep) or the indicated amount of rSec24C had
been added. The Sec24C status of the cytosols prior to the addition
of rSec24C is shown above the graph in immunoblots. In each case,
3
the H-TAG loaded PCTV were docked with intestinal Golgi and
3
the H-TAG-dpm associated with the Golgi determined. The dpm
3
(2946 H-TAG-dpm) found for PCTV formed in IgG depleted cyto3
sol was set to 100%. The data are the percentage of H-TAG dpm
associated with the Golgi by comparison to the dpm of IgG depleted cytosol. The data are the mean values ± 1 SEM, N = 4. ECL,
enhanced chemiluminescence; ER, endoplasmic reticulum; PCTV,
prechylomicron transport vesicle; TAG, triacylglycerol.

rSec24C mediates PCTV-Golgi SNARE complex
formation
We next wished to determine if the rSec24C added to
Sec24C immuno-depleted cytosol would not only promote
docking of PCTV with the Golgi but also would enable the
formation of the PCTV-Golgi SNARE complex preparatory to fusion. When Sec24C-depleted cytosol and PCTV
were incubated with Golgi membranes under conditions
where docking would be expected (see “Materials and
Methods”), no SNARE proteins for the PCTV-Golgi SNARE
complex at 112 kDa were found (Fig. 5, lane 1), nor was
any SNARE complex was found on boiling (Fig. 5, lane 2).
By contrast, when rSec24C, 29 µg, was incubated with
Sec24C-depleted PCTV prior to docking with the Golgi using Sec24C-depleted cytosol (2), a 112 kDa complex was
formed (Fig. 5, lane 3). This complex consisted of syntaxin5, VAMP7, vti1a, and, rBet1 (Fig. 5, lane 3) when the
sample was not boiled and DTT was not added. These
data, which support our prior studies (2), suggest that the
rSec24C was effective in bringing the PCTV close enough
to the Golgi to allow for SNARE complex formation. By
contrast to the complex formed when the proteins were
separated under mild conditions, when the proteins were
separated after boiling in Laemmle’s buffer, the SNARE
complex disassociated into its monomer components as
shown for each of the components (Fig. 5, lane 4). If the
Mr of the monomer species were added together, the expected Mr is 113 kDa, close to the Mr of 112 kDa as shown
in Fig. 5 for the SNARE complex. Contamination by ER
membranes potentially providing proteins important for
PCTV docking is unlikely because neither the cytosol nor

PCTV used contain the ER marker protein calnexin under
the conditions of our experiments (1, 14), and PCTV are
significantly less dense than ER (14).
It is possible that Sec24C removal by immuno-precipitation in some way changes either the structure or protein
composition of PCTV that affects their docking to the
Golgi by an alternate means other than the absence of
Sec24C. To address this question, we incubated PCTV with
anti-Sec24C antibodies under various conditions (Fig. 6).
IgG-treated intestinal cytosol and PCTV generated from it
were incubated with Golgi membranes and the amount of
docking determined (Fig. 6, bar 1). The docking activity
under these conditions compared with when no cytosol
was included in the incubation was set to 100%. By contrast, when Sec24C-depleted cytosol and PCTV were incubated with Golgi membranes (Fig. 6, bar 2), essentially no
PCTV were associated with the Golgi, confirming the data
shown in Fig. 3. Consistent with these data, when PCTV
were incubated with anti-Sec24C antibodies prior to its incubation with Golgi membranes, docking activity was reduced to 35% of the activity found under native conditions
(Fig. 6, bar 3). The incomplete antibody blockade could
be due to incomplete blocking of antigenic sites on Sec24C
or an inefficient blockade by the antibody, or recruitment
of Sec24C from the native cytosol to the PCTV.

DISCUSSION
COPII proteins are quintessential components of ER-toGolgi transport vesicles. Without them, no anterograde
transport occurs for newly synthesized proteins or other
1098
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Fig. 6. Sec24C antibody treatment of PCTV blocks it’s docking
3
with Golgi membranes. H-TAG loaded PCTV were generated using native cytosol and ER and docked with Golgi membranes. The
3
H-dpm found associated with the Golgi under these conditions
was set to 100% (bar1). In bar 2, cytosol and ER immunodepleted
of Sec24C was used to generate PCTV devoid of Sec24C that was
then incubated in Sec24C depleted cytosol with Golgi membranes.
3
The percentage of H-dpm found docked with the Golgi under
these conditions as compared with when native PCTV was used is
shown. In bar 3, PCTV formed using native cytosol and ER were
treated with 20 µl of anti-Sec24C antibody at 4°C for 30 min and
then incubated with native cytosol and Golgi in a docking assay.
3
The percentage of H-TAG-dpm associated with the Golgi under
these conditions as compared with the results obtained in bar 1 are
shown. The P values test the difference between the means for bar
1 and bar 3. The data are the mean ± SEM, N = 4. PCTV, prechylomicron transport vesicle; TAG, triacylglycerol.

potential cargoes that require export from the ER to the
Golgi. In humans, multiple mutations have been described
that both affect this process and highlight the importance
of its various components (20, 21). For the present report,
the most pertinent of the mutations is Chylomicron retention disease (CRD) in which Sar1b is mutated in the GTP
binding pocket, making the Sar1 component of the COPII
proteins inoperative (22). Also relevant to the present
data, cranio-lenticulo-sutural dysplasia (CLSD) has been
found due to a F382L-SEC23A mutation, proposed to be
caused by a reduced affinity of the Sec13/31 COPII component for the mutated Sec23A (23). In those tissues affected by the mutation, it was found that expression of the
potentially compensating SEC23B paralog of SEC23A was
low, leading to the effective loss of Sec23 function (23). In
sum, these data support the importance of COPII proteins
in ER-to-Golgi vesicle trafficking. The data in humans are
supported by a variety of in vitro studies using mutated
recombinant proteins.
In the iconic model of COPII protein–dependant vesicle formation, the process of vesicle cargo selection, membrane deformation, and fission is initiated by the exchange
of Sar1-GDP for GTP mediated by Sec12 at ERES. This
concept is supported by studies that show reduction in
vesicle formation in the presence of Sar1 mutated such
that it was unable to be inserted in the ER membrane (24)
or had a reduced affinity for GTP (25). However, more
recent work has shown that the GDP-GTP exchange oc-
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Fig. 5. The effect of Sec24C immuno-depletion on the formation
of the PCTV-Golgi SNARE complex. PCTV were generated using
Sec24C depleted cytosol and ER (Sec24C Depl, lanes 1 and 2) or
PCTV generated in Sec24C depleted cytosol and ER followed by
the incubation of the PCTV with rSec24C (29 µg) (Sec24C Depl,
rSec24C added, lanes 3 and 4). The PCTV were then docked with
the Golgi. Post docking, the Golgi membranes were isolated, solubilized in 2% Triton X-100, and the proteins immuno-precipitated
using bead-bound anti-VAMP7 antibodies. The beads were not
boiled or boiled in Laemmli’s buffer as indicated. The proteins
were separated by SDS-PAGE, transblotted, and the transblots
probed using specific antibodies to the expected SNARE proteins
(2). The blots shown are at 112 kDa, the Mr of the PCTV-Golgi
SNARE complex (2). On boiling, the SNARE proteins disassociated from the complex and moved at their monomer Mr (data not
shown). ER, endoplasmic reticulum; PCTV, prechylomicron transport vesicle.

that all of the COPII proteins on PCTV remain not only at
the tethering step but at the docking step as well. On fusion with the Golgi, the COPII proteins are found in
greatly diminished amount on the Golgi membranes, presumably because they have returned to the ER for additional rounds of COPII vesicle or PCTV transport.
The SAR1 gene has two paralogs, SAR1A and SAR1B,
which yield the expression of proteins that vary by 20
amino acids. While mutations in SAR1A have not been reported because they may be lethal, mutations in SAR1B
have (22, 32). Although the mutations and truncations of
the SAR1B gene vary, the phenotype resulting from these
genetic abnormalities yields the inability to mount a chylomicronemia after a fatty meal. If PCTV are produced in
the absence of Sar1 in vitro (1), why should the mutated
Sar1b protein lead to the absence of chylomicronemia in
vivo (32)? One possibility is that the PCTV that are produced in the absence of Sar1 do not fuse with the Golgi,
resulting in their retention in the cytosol. These immature
PCTV would then sequester proteins important for PCTV
generation on PCTV retained in the cytosol, making them
unavailable for recycling back to the ER to generate another round of PCTV. The return of these proteins to the
ER may control PCTV generation in the native state, supporting the observation that chylomicron exit from the ER
is the rate-limiting step in the transcellular movement of
neutral lipids (5). Further, with respect to the current observations, in the absence of Sar1, neither Sec24C nor
Sec31 are present on the PCTV produced under these
conditions (1). Thus the potential binding sites on Sec24C
for PCTV cargo proteins such as apoB48 (33) are not
enough to enable Sec24C binding to PCTV. The prior
binding of Sar1 is required.
Our data also supports prior data that COPII proteins
can be recruited back onto stripped vesicles, which enable
fusion (13). Here, PCTV generated in the absence of
Sec24C were unable to fuse with the Golgi. By contrast,
when the PCTV were incubated with rSec24C, the PCTV
readily fused with the Golgi.
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do not dock or fuse with the Golgi (1) by showing that in
contrast to COPII vesicles, all of the COPII proteins are
present at docking of PCTV with the Golgi. Also unlike
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